Five Deals Closed This Week. One $14.5B Merger Didn't Make It.
A genuine wave of completions this week — RMAX, TWO, ALOT, LEG, and FBRX all closed, several right on schedule. Not every deal made it across the line, though: Solstice and Element Solutions mutually terminated their $14.5B merger seven weeks after announcing it, and the market's reaction told you everything about how that deal was received in the first place. Shell's acquisition of ARC Resources is now just days from closing. AES cleared one regulatory gate this week, while a separate FERC fight stays the live open question. And our Risk/Reward Top 6 got rebuilt again, with a familiar name re-entering at the top of the annualized-return table.
71
Active Deals
1.82%
Median Spread
~$696B
Total Value
5
Closed This Week
This Week’s Top Moves
$ESI / $SOLSTERMINATED
A $14.5B merger nobody wanted, undone in seven weeks
Solstice — the acquirer, in an all-stock-and-cash deal for Element — mutually terminated with Element on August 27. No termination fees payable by either side, despite the agreement carrying $376M and $385M fee provisions for other walk scenarios. Both stocks had sold off hard after the July 6 announcement (Solstice about -21%, Element about -7%) on the unfocused-conglomerate read.
The kill landed after the close Thursday, alongside a new $500M buyback and a reaffirmation of the Q3/FY guidance Solstice had already raised at its July 30 Q2 beat — two separate events, not one. Friday's close was $63.53, up 12.8% from $56.34, after tagging $67.50 intraday: relief plus capital return, not an earnings print. Element fell as the buyout premium evaporated. A clean reminder that shareholder sentiment can still kill a deal with no financing or regulatory break in sight.
RMAX, TWO, ALOT, LEG, and FBRX all closed this week
A genuinely busy stretch for completions. $RMAX closed Aug 24 — Real Brokerage completed its acquisition, forming Real REMAX Group Inc. (now trading as REAX on Nasdaq). Cash elections exceeded the cap and were prorated, so cash electors ended up with roughly $4.33 cash plus 0.3535 REAX shares rather than the full cash amount; separately, we'd flagged and fixed a real modeling issue here days earlier after the election deadline passed, since late buyers no longer had a cash option at all and defaulted to the pure-stock outcome. $TWO closed Aug 25 — CrossCountry Mortgage's $12.00 cash plus the $0.20326 stub dividend, ending a roughly 20-month saga that included a prior UWM agreement, a switch to CCM, and three separate price raises. $ALOT and $LEG both closed the same day, Aug 26 — Arcline's $29.00 take-private of AstroNova, and Somnigroup's all-stock combination with Leggett & Platt. $FBRX closed Aug 27 — argenx's tender offer for Forte Biosciences cleared with 87.13% of shares validly tendered, settling at the full $77.00/share.
Shell's acquisition of ARC Resources received Investment Canada Act approval on August 25 — the last outstanding condition, following Competition Act, Canada Transportation Act, and US HSR clearances already in hand. A separate detail worth knowing: the Alberta Securities Commission also granted Shell exemptive relief tied to its UK/Netherlands share buyback program requirements, another condition now satisfied. ARC now guides to closing on or about September 2, 2026 — essentially a formality at this point, with the spread sitting under 1%.
CFIUS cleared this week; the real fight is still FERC
CFIUS approval landed August 27, satisfying that specific closing condition on the $33.4B GIP/EQT take-private. The live open question remains FERC: the Private Equity Stakeholder Project, joined by Public Citizen and Citizens Action Coalition Indiana, petitioned FERC (Docket EC26-99) to either block the deal outright or require BlackRock to break up its other utility holdings as a condition of approval — a filing from July, not new this week, but still the operative issue on the docket.
Worth real context: a similar challenge to BlackRock's 2024 Allete/Minnesota Power acquisition ultimately failed — FERC let that one proceed despite the same underlying concerns. This is advocacy-group opposition to a deal that cleared shareholders with 97.9% of votes cast in favor (about 67% of shares outstanding) and carries fully committed equity financing, not a sign of weakness in the deal process itself. Track the docket for how it resolves; the protest itself isn't a fresh escalation.
First real sign the widening trend might be turning
After four straight weekly checks of a steadily widening spread (19% → 26% → 31% → 34%), this week brought the first move in the other direction — back to 29.2%. One data point isn't a trend reversal, and the underlying risk (the Burdensome Condition clause naming BRCD directly) hasn't gone anywhere. A methodology note worth being explicit about: Sept 6 is an outside date, not an expected close date, and it auto-extends to Dec 6 if the only open items are the specified regulatory conditions — which is the actual basis for the annualized figure below, not the nearer date. After a month of one-directional bad news, a narrowing spread with no fresh negative catalyst behind it is still worth flagging on its own terms.
Vote date locked, and the regulatory boxes are checked
Iridium's special meeting to approve the Rocket Lab merger is now confirmed for September 24, 2026, with a straightforward majority-of-outstanding-shares threshold and 11 directors/officers already contractually committed to vote yes. HSR expired back on August 12 and the FCC transfer-of-control applications were filed August 10 — both major regulatory tracks are done. The one real variable left is financing mechanics: Rocket Lab is funding the cash portion via a $3.6B bridge loan it needs to refinance with permanent debt/equity before maturity. Real progress this month, on a still-long mid-2027 runway.
$WEAV — Weave Communications → Francisco Partners — $7.40 cash (~$650M, 34% premium) — Q4 2026 $BRBS — Blue Ridge Bankshares → HomeTrust Bancshares — 0.086 HTB shares, fixed ratio (~$448.1M) — Early Q1 2027 Note on $BRBS: this is a fixed exchange ratio, not a fixed-dollar offer, so the spread floats directly with HomeTrust's own stock price — it's tightened meaningfully since announcement as HTB has drifted lower, and now sits close to 2.5%. Also carries a real warrant-conversion election (deadline Sept 19) affecting final dilution, worth watching alongside the dual shareholder votes.
Binary Events on the Calendar
Sept 2 — $ARX/$SHEL close target. All regulatory approvals now in hand.
Sept 6 — $BHF outside date (extendable to Dec 6 only in specified circumstances).
Sept 9 — Israel's government-bodies decision on $ZIM/Hapag-Lloyd — the date that likely confirms whether this deal lives or dies.
Sept 24 — $IRDM shareholder vote. Director support agreements already in place; majority approval looks highly probable.
Sept 30 — $IMXI and $CCO close-adjacent dates.
Top 6 by Spread — August 30, 2026
Ticker
Deal
Spread
Key Risk
$BHF
Aquarian / Brighthouse
29.2%
Burdensome Condition clause names BRCD directly; spread may be turning
$ZIM
Hapag-Lloyd / ZIM
25.4%
Israel's Sept 9 decision remains the real catalyst
$NSC
Union Pacific / Norfolk Southern
14.0%
STB timeline now runs into H2 2027; opposition still live
$IRDM
Rocket Lab / Iridium
13.4%
Vote set for Sept 24; bridge-financing refinance is the last real risk
$IMXI
Western Union / Intermex
10.4%
DFPI reinstatement still pending; Nov 10 hard outside date
$GSAT
Amazon / Globalstar
9.7%
Satellite milestones progressing on schedule; cleanest docket tracked
Top 6 by Risk-Adjusted Expected Return — Rebuilt August 30
#
Ticker
Why
Gross Spread
Annualized
#1
$CCO
Still the cleanest deal-specific risk profile tracked — vote and HSR done, CFIUS the only remaining gate.
1.7%
~19%
#2
$PERF
81.2% of voting power locked into support agreements, fully self-funded, proper special-committee governance.
6.4%
~19%
#3
$WBD
Regulatory risk fully resolved; one well-defined variable (trial, March 2027) remains.
7.3%
~13%
#4
$IMXI
Back in the top tier. Highest raw annualized return in the group — the DFPI caveat hasn't changed, but hasn't worsened either, and WU carries no contractual right to walk.
10.4%
~119%
#5
$BHF
Second-highest annualized return in the book. Spread narrowed this week for the first time in over a month — worth watching, not yet a confirmed reversal.
29.2%
~108%
#6
$IRDM
Genuinely improving. HSR and FCC both cleared, vote scheduled Sept 24 with director support already locked in.
13.4%
~16%
What changed this week:$IMXI re-enters at #4 after being cut from the ranking two issues ago — the underlying facts haven't changed, but the annualized math is now simply too strong (highest in the group) to leave out over a caveat that's stayed static rather than gotten worse. $BHF holds #5 despite the spread narrowing slightly this week, since the underlying risk factor is unchanged. Gross spread and annualized return are now shown side by side in this table — a wide spread over a short window produces a large annualized figure even when the gross number looks more modest, but treat both figures below as best-case: $BHF's ~108% is measured against the Dec 6 outside date (98 days out), which itself only holds if the remaining issues stay purely regulatory; $IMXI's ~119% uses the Sept 30 target date, not the Nov 10 hard outside date that actually backstops the deal if DFPI hasn't reinstated by then. It's the annualized column that should drive sizing, with that caveat in mind.
Deals Removed This Week
$RMAX — RE/MAX Holdings × Real Brokerage — 0.515 REAX shares (deemed stock election) — CLOSED August 24 $TWO — Two Harbors × CrossCountry Mortgage — $12.00 cash + $0.20326 stub dividend — CLOSED August 25 $ALOT — AstroNova × Arcline — $29.00 cash — CLOSED August 26 $LEG — Leggett & Platt × Somnigroup — 0.1455 Somnigroup shares (~$2.3B) — CLOSED August 26 $FBRX — Forte Biosciences × argenx — $77.00 cash (tender + back-end merger) — CLOSED August 27 $ESI — Element Solutions × Solstice Advanced Materials — TERMINATED August 27 (mutual, no fees)
If you find ArbLens useful, consider sharing it with at least one person who might benefit — a fellow investor, analyst, or anyone who follows M&A. It’s free, and word of mouth is how this community grows. arblens.com
Real-time deal alerts, spread movements, and analysis as they happen — follow @ArbLens between issues.
Get weekly merger arb insights delivered to your inbox — spreads, regulatory updates, and what to watch next.
For informational purposes only. Nothing here constitutes investment advice. Merger arbitrage involves significant risk including deal failure and loss of capital. Data sourced from public filings and third-party sources. Spreads shown are as of August 30, 2026 and update nightly on arblens.com.